Rein Therapeutics
RNTX
1,54 €
Share price
0.00%
Change (1 day)
-73.01%
Change (1 year)
Categories
EPS for Rein Therapeutics (RNTX)
EPS in 2024 (TTM): -1,84 €
According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -1,80 €. In 2023 the company made an earnings per share (EPS) of -3,10 € an increase over its 2022 EPS that were of -5,46 €.
EPS history for Rein Therapeutics from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -1,84 € | -40.85% |
| 2023 | -3,10 € | -43.19% |
| 2022 | -5,46 € | 2.21% |
| 2021 | -5,34 € | -51.72% |
| 2020 | -11,07 € | -49.17% |
| 2019 | -21,78 € | -43.93% |
| 2018 | -38,84 € | -29.61% |
| 2017 | -55,17 € | 82.33% |
| 2016 | -30,26 € | 40.54% |
| 2015 | -21,53 € |